C
PFE icon

CFO4Life’s Pfizer PFE Stock Holding History

CFO4Life’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.47M Buy
+28,748
New +$1.38M 0.31% 51
2015
Q3 		– Sell
-6,453
Closed -$205K – 74
2015
Q2 		$205K Sell
6,453
-244
-4% -$7.95K 0.17% 76
2015
Q1 		$221K Buy
+6,697
New +$213K 0.18% 75

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CFO4Life's PFE Position: Q4 2022 in Review

CFO4Life opened a new position in Pfizer (PFE) in Q4 2022: 28,748 shares worth $1.47M. The stake represents 0.31% of the portfolio and ranks #51 among its holdings. This is a return to the name: CFO4Life previously reported a position in PFE as recently as Q2 2015.

CFO4Life first reported a position in PFE in Q1 2015 and has held it in 3 quarters since. 3,268 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • CFO4Life held 28,748 shares of Pfizer worth $1.47M as of Q4 2022.
  • Pfizer was a new CFO4Life position in Q4 2022.
  • Pfizer made up 0.31% of CFO4Life's portfolio in Q4 2022, its #51 holding.
  • CFO4Life first reported a position in Pfizer in Q1 2015 and has held it in 3 quarters since.
  • 3,268 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on CFO4Life's 13F filing for Q4 2022, filed 11 Jan 2023.